Extended-release naltrexone overlooked in opioid use disorders guideline
CMAJ
.
2018 Jul 16;190(28):E862.
doi: 10.1503/cmaj.69411.
Author
Launette M Rieb
1
Affiliation
1
Family physician and addiction medicine specialist; clinical associate professor, Department of Family Practice, Faculty of Medicine, University of British Columbia, Vancouver, BC.
PMID:
30012803
PMCID:
PMC6050113
DOI:
10.1503/cmaj.69411
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Naltrexone*
Narcotic Antagonists
Opioid-Related Disorders*
Substances
Narcotic Antagonists
Naltrexone
Grants and funding
R25 DA037756/DA/NIDA NIH HHS/United States